Topics: | Anemia of CKD | SGLT2 Inhibitors & CKD | Executive Order on Advancing Kidney Health

Navigating the Executive Order on Advancing American Kidney Health
and Other Kidney Policy Issues

 

Overview

Chronic kidney disease (CKD) and end-stage renal disease (ESRD) affect approximately 37 million and more than 720,000 Americans, respectively. Further, more than 100,000 Americans with ESRD are started on dialysis each year and 100,000 are on the waiting list to receive a kidney transplant. Unfortunately, the diagnosis and treatment of CKD are suboptimal as many patients progress to ESRD or kidney failure.

Accordingly, the President has issued an executive order on Advancing American Kidney Health to help prevent kidney failure through improvements in diagnosis and treatment as well as the incorporation of quality initiatives and incentives for preventative care.

The order recommends that reaching optimal outcomes require the use of higher value patient-centered care, patient education, the efficient use of organ transplants and advancements in the development of artificial kidneys. This educational program will review the newly released Executive Order on Advancing American Kidney Health, as well as discuss strategies for improving patient care and issues related to reimbursement for the management of patients with CKD and ESRD.

Agenda

I. Welcome and introduction
II. The Executive Order on Advancing American Kidney Health
III. Identifying patients with CKD at risk of disease progression and/or kidney failure
IV. Reimbursement code
V. Q&A session and concluding remarks

Learning Objectives

This program is designed to address the following National Academy of Medicine (NAM) competencies: provide patient-centered care and employ evidence-based practice.

At the conclusion of this activity, participants should be able to:

• Review the proposed changes to renal care outlined in the Executive Order on Advancing American Kidney Health
• Integrate strategies to identify and manage patients with CKD who are at-risk for disease progression
• Review current reimbursement codes regarding the treatment and management of patients with CKD and ESRD

Target Audience

This activity is intended for nephrologists and nurse practitioners who manage patients with chronic kidney disease (CKD).

Physician Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Physician Designation Statement

The Potomac Center for Medical Education designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information about the accreditation of this program, please email contact@potomacme.org.

ABIM MOC Designation Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

MIPS Credit Designation Statement

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

In order to fulfill requirements for MIPS improvement activity, participants will need to fill out 2 brief follow-up surveys at 30- and 90-days post-activity.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Rockpointe Corporation.Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.3 contact hours.

Steering Committee

Michael Ly
Director of Public Policy
American Kidney Fund
Rockville, MD

Disclosure Statement

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.

Disclosures will be made known to participants prior to the activity.

Jointly provided By

Provided By